That can only come from payers and progress has been growing but slowly. One of the biggest hurdles for DTx uptake, including solutions that require a prescription, is reimbursement scale. DTx consists of "evidence-based therapeutic interventions that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease." This includes wearables, other personal and home-based software and devices, and DTx, or digital therapeutics. Employers can use ICHRA to give employees a set amount of money to purchase coverage and offset cost-sharing.ĭigital therapeutics learns more about commercializationĬonsumer-driven healthcare is the rising tide that will lift many boats. They are also taking advantage of new funding models such as ICHRA, or Individual Coverage Health Reimbursement Arrangement. Across the industry, self-insured employers are also exploring direct contracting with providers. PBGH strategies include integrating public and private purchaser efforts. This includes a "redirect" of member spend and purchasing toward affordable, whole-person, equitable care. Look for the Purchaser Business Group on Health (PBGH) and its dozens of large employer members to act on new strategic goals. They will continue to take strong actions to counter them. Managed Executive also predicts that 2023 will be "a breakout year for value-based care."Įquality Health chief strategy officer Brandon Clark writes: "Across the past two years of the pandemic, we better understand that ground-up redesign is an imperative and not an option." Noting CMS' increased focus on VBC, Clark identifies other drivers: "The fee-for-service model is creating provider burnout at alarming rates, and the pandemic shed a major light on social and cultural health inequities." Employers own their payer roleĪs HealthLeaders highlighted throughout 2022, employers appear fed up with healthcare costs.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |